Xiaochen Yang1, Hong Zhao2, Jie Wang3. 1. Department of Cardiology, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing 100053, China. 2. Department of Acupuncture, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing 100053, China. 3. Department of Cardiology, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing 100053, China. Electronic address: wangjie_gamyy@126.com.
Abstract
BACKGROUND: Chinese massage, named Tuina, is commonly used in China and potentially effective for essential hypertension (EH). However, there is no critically appraised evidence such as systematic reviews or meta-analyses on the effectiveness and safety of Tuina for EH. METHODS: The following electronic databases: Pubmed, the Cochrane library, CNKI, the Wan Fang Database and VIP were searched for published and unpublished randomized controlled trials (RCTs) of Tuina for EH up to 20th August 2013. RESULTS: Seven randomized trials involving 479 patients were included. The results of meta-analysis showed superior effects of Tuina plus antihypertensive drugs compared to antihypertensive drugs alone, however, Tuina alone was not superior to antihypertensive drugs. The safety of Tuina for EH was still unclear because adverse effects were not assessed in most of the original trials. CONCLUSIONS: The findings from our review suggest that Tuina might be a beneficial adjuvant for patients with EH, although the results are of limited value due to the clinical heterogeneity and low methodological quality of the included studies. Future studies should adhere to high-quality RCTs with long follow-up for demonstrating the effectiveness of Tuina for inpatients with EH.
BACKGROUND: Chinese massage, named Tuina, is commonly used in China and potentially effective for essential hypertension (EH). However, there is no critically appraised evidence such as systematic reviews or meta-analyses on the effectiveness and safety of Tuina for EH. METHODS: The following electronic databases: Pubmed, the Cochrane library, CNKI, the Wan Fang Database and VIP were searched for published and unpublished randomized controlled trials (RCTs) of Tuina for EH up to 20th August 2013. RESULTS: Seven randomized trials involving 479 patients were included. The results of meta-analysis showed superior effects of Tuina plus antihypertensive drugs compared to antihypertensive drugs alone, however, Tuina alone was not superior to antihypertensive drugs. The safety of Tuina for EH was still unclear because adverse effects were not assessed in most of the original trials. CONCLUSIONS: The findings from our review suggest that Tuina might be a beneficial adjuvant for patients with EH, although the results are of limited value due to the clinical heterogeneity and low methodological quality of the included studies. Future studies should adhere to high-quality RCTs with long follow-up for demonstrating the effectiveness of Tuina for inpatients with EH.
Authors: Ning Dai; Qingyun He; Xuehan Liu; Min Fang; Min Xiong; Xun Li; Duoduo Li; Jianping Liu Journal: Qual Life Res Date: 2022-08-17 Impact factor: 3.440
Authors: Francesco Cerritelli; Marco Chiera; Marco Abbro; Valentino Megale; Jorge Esteves; Alberto Gallace; Andrea Manzotti Journal: Front Neurol Date: 2021-06-30 Impact factor: 4.003